Opioids Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Opioids stocks.

Opioids Stocks Recent News

Date Stock Title
Nov 15 LQDA Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off
Nov 15 LQDA Liquidia Third Quarter 2024 Earnings: Beats Expectations
Nov 14 DRRX Q3 2024 DURECT Corp Earnings Call
Nov 14 MJ Cannabis stocks gain as Trump picks pro-marijuana Congressman Gaetz for AG post
Nov 14 COLL Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest
Nov 14 DRRX Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ...
Nov 14 LQDA Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ...
Nov 14 DRRX DURECT Corporation (DRRX) Q3 2024 Earnings Call Transcript
Nov 13 DRRX Durect (DRRX) Reports Q3 Loss, Misses Revenue Estimates
Nov 13 DRRX Durect: Q3 Earnings Snapshot
Nov 13 AMPH Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Nov 13 DRRX DURECT GAAP EPS of -$0.14 beats by $0.03, revenue of $1.92M misses by $0.06M
Nov 13 DRRX DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update
Nov 13 LQDA Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript
Nov 13 COLL Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now?
Nov 13 LQDA Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Tops Revenue Estimates
Nov 13 LQDA Liquidia GAAP EPS of -$0.30 beats by $0.07, revenue of $4.45M beats by $0.26M
Nov 13 LQDA Liquidia Corporation Reports Third Quarter 2024 Financial ResultsĀ and Provides Corporate Update
Nov 13 ASRT Assertio Holdings Third Quarter 2024 Earnings: Beats Expectations
Nov 13 DRRX Earnings Scheduled For November 13, 2024
Opioids

Opioids are substances that act on opioid receptors to produce morphine-like effects. Medically they are primarily used for pain relief, including anesthesia. Other medical uses include suppression of diarrhea, replacement therapy for opioid use disorder, reversing opioid overdose, suppressing cough, suppressing opioid induced constipation, as well as for executions in the United States. Extremely potent opioids such as carfentanil are only approved for veterinary use. Opioids are also frequently used non-medically for their euphoric effects or to prevent withdrawal.

Side effects of opioids may include itchiness, sedation, nausea, respiratory depression, constipation, and euphoria. Tolerance and dependence will develop with continuous use, requiring increasing doses and leading to a withdrawal syndrome upon abrupt discontinuation. The euphoria attracts recreational use and frequent, escalating recreational use of opioids typically results in addiction. An overdose or concurrent use with other depressant drugs commonly results in death from respiratory depression.Opioids act by binding to opioid receptors, which are found principally in the central and peripheral nervous system and the gastrointestinal tract. These receptors mediate both the psychoactive and the somatic effects of opioids. Opioid drugs include partial agonists, like the anti-diarrhea drug loperamide and antagonists like naloxegol for opioid-induced constipation, which do not cross the blood-brain barrier, but can displace other opioids from binding to those receptors.
Because opioids are addictive and may result in fatal overdose, most are controlled substances. In 2013, between 28 and 38 million people used opioids illicitly (0.6% to 0.8% of the global population between the ages of 15 and 65). In 2011, an estimated 4 million people in the United States used opioids recreationally or were dependent on them. As of 2015, increased rates of recreational use and addiction are attributed to over-prescription of opioid medications and inexpensive illicit heroin. Conversely, fears about over-prescribing, exaggerated side effects and addiction from opioids are similarly blamed for under-treatment of pain.

Browse All Tags